Skip to main content
Log in

Anti-inflammatory pharmacology and mechanism of the orally active capsaicin analogs, NE-19550 and NE-28345

  • Inflammation and Immunomodulation
  • Published:
Agents and Actions Aims and scope Submit manuscript

Abstract

We have evaluated the properties of a new class of anti-inflammatory agents derived from capsaicin, using the analogs NE-19550 (N-vanillyloleamide) and NE-28345 (N-oleyl-homovanillamide) as examples. This class displayed an atypical profile in the assays utilized, including 1) anti-edema and antileukocyte migration activity in the rat carrageenan pleurisy assay without suppression of pleural prostanoid synthesis, 2) blockade of human platelet aggregation induced by arachidonate or PAF but not that induced by the PGH2 analog U-46619, without equivalent inhibitionin vitro of mammalian cyclooxygenase or thromboxane synthetase preparations, 3) greater potency and efficacy in the rat implanted sponge assay than in the adjuvant arthritis assay, without inhibition of LTB4 or 15-HETE synthesisin vitro, 4) stronger topical activity in the mouse croton oil inflamed ear assay than the guinea pig UV erythema assay, and 5) oral activity in the rat carrageenan paw edema assay and mouse phenylquinone abdominal constriction rest combined with failure to induce gastric erosion in rats at therapeutic doses. We conclude that NE-19550 and NE-28345 do not act like conventional NSAIDs via suppression of arachidonic acid metabolism.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. R. J. Flower and J. R. Vane,Inhibition of prostaglandin synthetase in brain explains the anti-pyretic activity of paracetamol. Nature240, 410–411 (1972).

    PubMed  Google Scholar 

  2. S. H. Ferreira, S. Moncada and J. R. Vane,Further experiments to establish that the analgesic action of aspirin-like drugs depends on the inhibition of prostaglandin biosynthesis. Br. J. Pharmacol.47, 629P-630P (1973).

    PubMed  Google Scholar 

  3. G. A. Higgs, R. J. Flower and J. R. Vane,A new approach to anti-inflammatory drugs. Biochem. Pharmacol.28, 1959–1961 (1979).

    Article  PubMed  Google Scholar 

  4. G. A. Higgs, K. G. Mugridge, S. Moncada and J. R. Vane,Inhibition of tissue damage by the arachidonate lipoxygenase inhibitor BW755c. Proc. Natl. Acad. Sci. USA81, 2890–2892 (1984).

    PubMed  Google Scholar 

  5. E. Vallee, J. Gougat, J. Navarro and J. F. Delahayes,Anti-inflammatory and platelet anti-aggregant activity of phospholipase A 2 inhibitors. J. Pharm. Pharmacol.31, 588–592 (1979).

    PubMed  Google Scholar 

  6. M. Fitzgerald,Capsaicin and sensory neurones—a review. Pain5,109–130 (1983).

    Article  Google Scholar 

  7. T. R. Laflann and R. W. Farmer,Anti-nociceptive actions of capsaicin in rodents. Proc. West. Pharmacol. Soc.26, 145–149 (1983).

    PubMed  Google Scholar 

  8. L. M. Brand, K. L. Skare, M. E. Loomans, M. L. Skoglund, H. H. Tai, C. Chiabrando and R. Fanelli,NE-19550, an anti-inflammatory analgesic with a novel mechanism. Fed. Proc.45, 334 (1986).

    Google Scholar 

  9. L. M. Brand, E. F. Berman, R. J. Schwen, M. E. Loomans, J. M. Janusz, R. Bohne, C. Maddin, J. Garnder, T. Leflann, R. Farmer, L. Jones, C. Chiabrando and R. Fenelli,NE-19550: a novel, orally active anti-inflammatory analgesic. Drugs Exptl. Clin. Res. XIII, 259–265 (1987).

    Google Scholar 

  10. F. E. Dewhirst,Structure-activity relationships for inhibition of prostaglandin cyclooxygenase by phenolic compounds. Prostaglandins20, 209–222 (1980).

    PubMed  Google Scholar 

  11. H. Wagner, M. Wierer and R. Bauer,Anti-inflammatory drugs, part 3. In vitro inhibition of prostaglandin biosynthesis by essential oils and phenolic compounds. Planta Med.3, 184–187 (1986).

    PubMed  Google Scholar 

  12. F. Kuichi, M. Shibuya and U. Sankawa,Inhibitors of prostaglandin biosynthesis from ginger. Chem. Pharm. Bull.30, 754–757 (1982).

    PubMed  Google Scholar 

  13. D. L. Flynn, M. F. Rafferty and A. M. Boctor,Inhibition of human neutrophil 5-lipoxygenase activity by gingerdione, shogaol, capsaicin and related pungent compounds. Prostaglandins Leukotrienes Med.24, 195–198 (1986).

    Article  Google Scholar 

  14. S. Ikawami, S. Shibuya, C. F. Tseng, F. Hanoaka and U. Sankawa,Inhibition of arachidonate 5-lipoxygenase by phenolic compounds. Chem. Pharm. Bull.34, 3960–3963 (1986).

    PubMed  Google Scholar 

  15. K. Miyaska and T. Mikami,Comparison of the antiinflammatory effects of dexamethasone, indomethacin and BW755c on carrageenan-induced pleurisy in rats. Eur. J. Pharmacol.77, 229–236 (1982).

    Article  PubMed  Google Scholar 

  16. K. E. Fahrenholz, M. Z. Silverweis, N. Germane, H. J. Crowley, D. A. Sinko and C. Dalton,3-Phenyl-5-[2,2,2-trifluoro-1-hydroxy(trifluoromethyl) ethyl]indole-2-carbonitrile, a potent inhibitor of prostaglandin synthetase and platelet aggregation. J. Med. Chem.22, 948–953 (1979).

    Article  PubMed  Google Scholar 

  17. C. Chiabrando, A. Noseda, M. N. Castagnoli, M. Salmona and R. Fanelli,Characterization of arachidonic acid metabolic profiles in animal tissues by high resolution gas chromatography-mass spectrometry. Biochim. Biophys. Acta794, 292–297 (1984).

    PubMed  Google Scholar 

  18. H. H. Tai and B. Yuan,On the inhibitory potency of imidazole and its derivatives on thromboxane synthetase. Biochem. Biophys. Res. Comm.80, 236–242 (1978).

    Article  PubMed  Google Scholar 

  19. G. C. Gairola and H. H. Tai,Cigarette smoke-induced alterations in the release of arachidonate metabolites by pulmonary alveolar macrophages from selenium-fed and selenium-deficient rats. Biochem. Pharmacol.35, 2423–2428 (1986).

    Article  PubMed  Google Scholar 

  20. A. Blackham, A. A. Norris and F. A. Woods,Models for evaluating the anti-inflammatory effects of inhibitors of arachidonic acid metabolism. J. Pharm. Pharmacol.37, 787–793 (1985).

    PubMed  Google Scholar 

  21. Z. E. Mielens, K. Connoly and V. J. Stecher,Effect of disease-modifying antirheumatic drugs and nonsteroidal anti-inflammatory drugs upon cellular and fibronectin responses in a pleurisy model. J. Rheumatol.12, 1083–1087 (1985).

    PubMed  Google Scholar 

  22. F. Lembeck and J. Donnerer,Time course of capsaicin-induced functional impairments in comparison with changes in neuronal substance P content. Naunyn Schmiedebergs Arch. Pharmacol.316, 240–243 (1981).

    Article  PubMed  Google Scholar 

  23. A. Saria, J. M. LUndberg, G. Skofitsch and F. Lembeck,Vascular protein linkage in various tissue induced by substance P, capsaicin, bradykinin, serotinin, histamine and by antigen challenge. Naunyn Schmiedebergs Arch. Pharmacol.324, 212–218 (1983).

    Article  PubMed  Google Scholar 

  24. R. A. Karmali and B. Safai,Ultraviolet-evoked prostaglandin biosynthesis in varying stages of keratinocyte differentiation in guinea pig skin. Prostaglandins Leukotrienes Med.15, 277–286 (1984).

    Article  Google Scholar 

  25. G. G. Moore and K. F. Swingle,2,6-Di-tert-butyl-4-(2-thenoyl)phenol (R-830): a novel non-steroidal anti-inflammatory agent with antioxidant properties. Agents and Actions12, 674–683 (1982).

    Article  PubMed  Google Scholar 

  26. R. Vinegar, J. F. Truax, J. L. Selph and F. A. Voelker,Pathway of onset, development and decay of carrageenan pleurisy in the rat. Fed. Proc.41, 2588–2595 (1982).

    PubMed  Google Scholar 

  27. A. P. Green, F. R. Morgan, M. J. Thrompson, K. E. Randall and E. A. Boyle,BRL 20459, a novel topically active nonsteroidal anti-inflammatory drug. J. Pharm. Pharmacol.36, 314–317 (1984).

    PubMed  Google Scholar 

  28. J. D. Levine, R. Clark, M. Devor, C. Helms, M. A. Moskowitz and A. I. Busbaum,Intraneuronal substance P contributes to the severity of experimental arthritis. Science226, 547–549 (1984).

    PubMed  Google Scholar 

  29. M. Lotz, D. A. Carson and J. H. Vaughn,Substance P activation of rheumatic synoviocytes: neural pathway in the pathogenesis of arthritis. Science235, 893–895 (1987).

    PubMed  Google Scholar 

  30. F. C. Colpaert, J. Donnerer and F. Lembeck,Effects of capsaicin on inflammation and on the substance P content of nervous tissues in rats with adjuvant arthritis. Life Sci.32, 1827–1834 (1983).

    Article  PubMed  Google Scholar 

  31. A. Hara, T. Sakurada, S. Sakurada, H. Matsumura, R. andoh and K. Kisara,Effects of capsaicin on adjuvant-induced chronic pain in rats. Ann. Rep. Tohoku Coll. Pharm.31, 153–159 (1984).

    Google Scholar 

  32. R. D. Inman, B. Chiu, S. Rabinovich and W. Marshall,Neuromodulation of synovitis capsaicin effect on severity of experimental arthritis. J. Neuroimmunol.24, 17–22 (1989).

    Article  PubMed  Google Scholar 

  33. F. Y. Lam and W. R. Ferrell,Capsaicin suppresses substance P-induced joint inflammation in the rat. Neuroscience Letters105, 155–158 (1989).

    Article  PubMed  Google Scholar 

  34. A. K. De and J. J. Ghosh,Inflammatory effects of acute and chronic capsaicin treatment on rat paw. Phytotherapy Research2, 175–179 (1988).

    Google Scholar 

  35. A. Saria,Substance P in sensory nerve fibres contributes to the development of oedema in the rat hind paw after thermal injury. Br. J. Pharmacol.82, 217–222 (1984).

    PubMed  Google Scholar 

  36. J. P. Wang, M. F. Hsu and C. M. Teng,Antiplatelet effect of capsaicin. Thromb. Res.36, 497–507 (1984).

    Article  PubMed  Google Scholar 

  37. J. Maclouf, S. Levy-Toledano, E. Savariau, R. Hardisty and J. P. Chen,Arachidonic acid-induced platelet aggregation independent of cyclooxygenase and lipoxygenase. Prostaglandins28, 383–398 (1984).

    Article  PubMed  Google Scholar 

  38. T. J. Hallam, A. Sanchez and T. J. Rink,Stimulus-response coupling in human platelets. Changes evoked by platelet-activating factor in cytoplasmic free calcium monitored with the fluorescent calcium indicator quin2. Biochem. J.218, 819–827 (1984).

    PubMed  Google Scholar 

  39. D. Lauri, C. Carletti and G. deGaetano,Amplification of the primary response of human platelets to platelets activating factor: aspirin sensitive and aspirin-insensitive pathways. J. Lab. Clin. Med.105, 653–658 (1985).

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brand, L.M., Skare, K.L., Loomans, M.E. et al. Anti-inflammatory pharmacology and mechanism of the orally active capsaicin analogs, NE-19550 and NE-28345. Agents and Actions 31, 329–340 (1990). https://doi.org/10.1007/BF01997628

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01997628

Keywords

Navigation